Bilal F Anouti

Bilal F Anouti serves as an Assistant Professor in the Department of Medicine within the Feinberg School of Medicine at Northwestern University. He is a dedicated physician-scientist at Northwestern Medicine, focusing on hematology and oncology with a commitment to advancing cancer care through research and clinical practice.

His research interests encompass oncology and hematology, with specific expertise in lung cancer (including NSCLC and SCLC), germ cell tumors, cancer-related pain management, and medical education. Dr. Anouti's work aims to improve therapeutic strategies and patient outcomes in these areas through clinical trials and translational research.

Analysis of his recent publications reveals a consistent focus on clinical oncology, particularly novel combination therapies for lung cancer, maintenance strategies for germ cell tumors, and epidemiological studies of cancer pain in diverse populations. His educational research advocates for innovative hybrid training models in oncology residency programs to enhance clinical education.

Scientific awards: None mentioned in the provided profile.

Dr. Anouti is actively leading clinical research as Principal Investigator for trial NCT06362252 evaluating ifinatamab deruxtecan in extensive-stage small cell lung cancer. His portfolio demonstrates strong engagement in therapeutic development and medical education initiatives, though specific advising roles and grant details beyond active trials are not documented in the source material.